Previous Close | 53.00 |
Open | 53.50 |
Bid | 53.50 x N/A |
Ask | 55.50 x N/A |
Day's Range | 53.50 - 53.50 |
52 Week Range | 32.00 - 61.00 |
Volume | |
Avg. Volume | 11 |
Market Cap | 39.229B |
Beta (5Y Monthly) | 0.64 |
PE Ratio (TTM) | 58.79 |
EPS (TTM) | 0.91 |
Earnings Date | Jul 25, 2024 |
Forward Dividend & Yield | 0.41 (0.77%) |
Ex-Dividend Date | May 15, 2024 |
1y Target Est | N/A |
Despite a net loss, MRVI showcases strategic expansions and robust partnerships, setting the stage for future growth.
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update.
Lonza Group ( VTX:LONN ) Full Year 2023 Results Key Financial Results Revenue: CHF6.72b (up 7.9% from FY 2022). Net...